Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 28, 2017- First targeted biologic in the European Union to receive marketing authorization for use in atopic dermatitis -
-
Sep 16, 2017- Late-breaking oral abstract of Phase 3 CAFÉ study presented at the 26th European Academy of Dermatology and Venereology (EADV) Congress -
-
Jun 11, 2017- Data presented at the 77th Scientific Sessions of the American Diabetes Association (ADA) -
-
Jun 4, 2017- Oral presentation provides first REGN2810 data in patients with advanced cutaneous squamous cell carcinoma (CSCC) -
-
May 22, 2017- Kevzara is now available to U.S. patients -
-
May 11, 2017-- New Initiative Encourages Americans to Help Reduce Air Pollution & Enjoy the Outdoors this Spring Allergy Season --
-
Apr 28, 2017- New action date for Kevzara U.S. BLA is May 22, 2017 -
-
Apr 25, 2017- Monthly dosing schedule now approved in both United States and European Union -
-
Apr 24, 2017- New U.S. indication approved for Thymoglobulin [anti-thymocyte globulin (rabbit)]; first since 1998 -
-
Apr 3, 2017- New toothpaste introduced by the trusted leader in mouthwashes for more than 30 years helps motivate kids to brush their teeth -
-
Mar 28, 2017- Dupixent will be available later this week to U.S. patients suffering from this chronic and debilitating form of eczema -
-
Mar 21, 2017The makers of Xyzal® Allergy 24HR, now available over-the-counter (OTC) at full prescription strength, are teaming up with Dr. Neeta Ogden to Encourage Allergy Sufferers to 'Wise Up, Rise Up'
-
Mar 4, 2017- Late-breaking oral abstract to be presented today at the Annual Meeting of the American Academy of Dermatology -
-
Feb 8, 2017- Praluent continues to be available to patients in the U.S. -
-
Feb 1, 2017- Antihistamine Offers 24-Hour Relief to Adults and Children with Seasonal and Year-Round Allergies -
-
Nov 16, 2016- In the MONARCH Study, Sarilumab Monotherapy Demonstrated Superiority Over Adalimumab Monotherapy in Adults with Active Rheumatoid Arthritis -
-
Mar 4, 2016Praluent is now covered by most health insurance and Medicare plans
-
Feb 12, 2016America's Leading National Consumer Research Survey Ranks ACT Advanced Care #1 in "Oral Care" Category
-
Feb 2, 2016Six researchers each receive $1.625 million in "Pathway to Stop Diabetes®" awards
-
Dec 11, 2015Praluent® is the only PCSK9 inhibitor preferred across UnitedHealth Group formularies, including OptumRx and UnitedHealthcare Commercial, Medicare, and Managed Medicaid formularies
-
Dec 1, 2015New 24 and 32-Packs Designed to Manage Dosage Regimens for both Latent and Active Tuberculosis
-
Nov 10, 2015- 74 percent of patients reached their LDL cholesterol goals on 75 mg dose; Of the remaining patients whose dose was adjusted to 150 mg, most achieved their goal -
-
Nov 8, 2015- Data Show Significant Improvement in Signs and Symptoms and Physical Function in Rheumatoid Arthritis Patients who were Inadequate Responders to or Intolerant of TNF-Alpha Inhibitors (TNF-IR) -
-
Aug 31, 2015- Will work together on new digital technology and tools for diabetes -
-
Jun 30, 2015Sanofi and Regeneron Engage Academy Award® Winning Documentarian to Capture Behind-the-Scenes Look at Life with an Invisible Condition
-
Mar 18, 2015Allergy sufferers are encouraged to share the #HappySmells they experience this season
-
Feb 11, 2015America's Leading National Consumer Research Survey Ranks Gold Bond Products #1 in "U.S. Body Comfort and Relief" and "U.S. Skincare" Categories
-
Nov 18, 2014IcyHot SmartRelief System Provides Physical Therapist-Trusted TENS Technology for Persistent, Chronic Back Pain Relief That Starts at the Touch of a Button
-
Nov 11, 2014- Dupilumab Demonstrated Improvement in Lung Function, Reductions of Severe Exacerbations -
-
Aug 13, 2014- Study Demonstrates Fluzone High-Dose Vaccine 24.2 Percent More Effective Than Standard-Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older -
-
Jul 30, 2014- Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor -
-
Apr 1, 2014New investigational PCSK9 inhibitor shown to significantly reduce LDL-C among Japanese patients
-
Feb 4, 2014First and only medicine in its class approved for over-the-counter use that provides 24 hour relief of the full range of nasal allergy symptoms including nasal congestion
-
Dec 19, 2013- Collaboration represents the first time the ACC’s PINNACLE Registry Research Alliance will be used for clinical trial recruitment -
-
Oct 11, 2013- Nasal Spray Treats Adults and Children with Seasonal and Year-Round Nasal Allergies -
-
Aug 20, 2013- Majority of Survey Respondents Reported They or Their Child Experienced a Severe Allergic Reaction While Traveling -
-
Jun 22, 2013- EDITION I demonstrated similar blood sugar control with fewer night-time low blood sugar events compared to Lantus® -
-
Jun 22, 2013-- Lixisenatide decreased HbA1c by reducing PPG when added to basal insulin with or without oral anti-diabetic agents --
-
May 16, 2013- Bettis Unveils New Playbook for Defending Against Severe Allergic Reactions and Urges Those Affected to Take Action -
-
May 6, 2013The same trusted formula in an easy aim spray
-
May 6, 2013-Donation to Diabetes Hands Foundation Doubled When Documentary Reaches 10,000 Views-
-
Mar 21, 2013National Patient Spokesperson Melanie Bloom Commemorates Significant Achievements to Raise Awareness of DVT and Potentially Fatal Complication, Pulmonary Embolism
-
Jan 29, 2013--LeGoo® proprietary gel technology provides clear surgical field for cardiothoracic and vascular surgeons without trauma to blood vessels--
-
Aug 13, 2012-- Breakthrough device design talks patients and caregivers through the injection process --
-
Jun 11, 2012- No increased risk of cancer found with Lantus® in new European and U.S. observational studies -
-
Jun 9, 2012- Lixisenatide with basal insulin helped type 2 diabetes patients with uncontrolled HbA1c achieve target blood glucose levels -
-
May 2, 2012- First FDA Cleared Blood Glucose Meter that Connects Directly to iPhone® and iPod touch® -
-
Apr 24, 2012Birmingham Program to Improve Diabetes Management through Behavioral Economics
-
Mar 7, 2012Fewer Than One in Three Survey Participants Discussed DVT/PE with Healthcare Professional
-
Feb 7, 2012-- Product to be commercialized by Sanofi Pasteur U.S. - an established leader in pediatric healthcare --
-
Nov 16, 2011Local Demonstration Program to Implement Community-Based Diabetes Management Announced
-
Nov 11, 2011Sanofi Collaborates with Leading Health Organizations to Help Men Take More Proactive Stance in Managing Their Disease
-
Oct 5, 2011- Findings from Two-Year Pivotal Phase III TEMSO Trial Published today in The New England Journal of Medicine -
-
Oct 3, 2011Nationwide Recipe Contest Elevates Awareness for Proper Diabetes Management
-
Sep 27, 2011AFib Educator 2.0" Includes New Animations, Resources to Improve Patient-Physician Dialogue
-
Sep 13, 2011National AFib Education Campaign Launches to Help Improve the Care of People with This Serious and Increasingly Prevalent(1) Form of Irregular Heartbeat
-
Sep 12, 2011- Weight gain was lowest in patients with baseline A1C below 8 percent and in patients 65 years and older -
-
Sep 12, 2011- New phase III data from GetGoal-F1 study of once-daily lixisenatide support simplified treatment initiation -
-
Jun 7, 2011Diabetes Co-Stars: Cook-Off Invites People to Share Diabetes-Friendly Recipes
-
Jun 4, 2011- Results of Phase III SAVE-ONCO study selected for "Best of ASCO 2011" -
-
Mar 22, 2011"AFib in America: State Impact Reports" Illustrate the Disconnect Between AFib's Impact and the Public Health Resources Available
-
Mar 9, 2011The Coalition to Prevent DVT Promotes Education to Fill the Gap between DVT Risk and Co-Morbid Patients
-
Dec 9, 2010Final 10-year combination chemotherapy adjuvant survival data, studies of investigational agent iniparib to be featured at breast cancer symposium
-
Oct 1, 2010- Results of the Phase III TROPIC global study published -
-
Sep 22, 2010Repeated Doctors Visits, ER Trips, and Admissions to Inpatient/Outpatient Facilities Create High Costs for Managing Patients with a Common, Complex Cardiovascular Disease
-
Sep 21, 2010-'Diabetes Co-Stars' Offers Information and Support to People Living with Diabetes, Family and Friends -
-
Sep 20, 2010- Findings Presented at European Association for the Study of Diabetes (EASD) 46th Annual Meeting -
-
Sep 20, 2010- Phase III Study Results also demonstrated the therapy had acceptable safety profile -
-
Jun 26, 2010- Study Findings Presented at American Diabetes Association's 70th Annual Scientific Sessions -
-
Jun 17, 2010- First and only therapy to provide significant survival benefit in second-line metastatic hormone-refractory prostate cancer -
-
Apr 1, 2010Interactive Exhibit Unveiled at New Jersey's Liberty Science Center as it Embarks on Three-Year, 12-City Tour
-
Mar 3, 2010- Results observed in patients treated with cabazitaxel plus prednisone whose disease progressed despite prior docetaxel-based chemotherapy -